A large meta-analysis of SGLT2 inhibitor trials found consistent cardiovascular benefits in diverse subsets of patients with type 2 diabetes, including those without established cardiovascular disease. The study showed a significant reduction in major adverse cardiac events, cardiovascular deaths, and hospitalizations for heart failure.
A recent study published in Neurology found that women are more likely to survive a stroke, but experience worse disability and reduced quality of life compared to men. The research suggests that variations in hospital treatment and risk factor management may contribute to these differences.
Experts recommend requiring salt shakers to carry front-of-pack health warnings to raise consumer awareness about excess salt consumption. The World Health Organization aims to reduce sodium intake by 30% by 2025, and warning labels could help people make healthier choices.
A new meta-analysis found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease by about 30% and also reduce the risk of acute kidney injury. The results are encouraging for people with diabetic kidney disease, offering a new treatment option to halt disease progression.
The UK topped the charts with an average Health Star Rating of 2.83, followed by the US and Australia. Meanwhile, China's packaged foods scored lowest due to high levels of saturated fat and sugar.
A global study of 12 million people found that diabetes significantly increases the risk of heart failure, with women at greater risk than men. Type 1 and type 2 diabetes both pose a stronger risk for women, highlighting the need for sex-specific research into diabetes and its impact on heart health.
Researchers found that intensive blood pressure lowering reduces the risk of bleeding in the brain after 'clot-busting' treatments for acute ischaemic stroke, making thrombolysis safer. However, this didn't translate to improved overall outcomes for patients.
Researchers aim to evaluate a low dose blood-thinning medication for people with advanced kidney disease, a condition affecting over 30.5 million globally. The five-year trial will also investigate the safety of this medication in reducing heart attacks, strokes and deaths.
Research from The George Institute for Global Health found that women in China are 7% more aware of hypertension, 6% more likely to use antihypertensive medications, and 3% more likely to control their blood pressure levels. However, levels across all categories were low, with only 17% of participants in control.
A study of 472,000 participants found that women with these conditions experience a higher relative risk of heart attack compared to men. The excess risk persists even in older age and could lead to an additional burden on society.
A new study found that young adults classified as obese in Australia can expect to lose up to 10 years of life expectancy. The study also predicts 36.3 million years of life will be lost due to overweight and obesity over the lifetime of today's Australian adult population.
A new low-dose three-in-one pill has been shown to effectively treat high blood pressure in most patients, with a 70% success rate compared to half receiving normal care. The 'Triple Pill' is simpler and more cost-effective than traditional treatment methods.
A global review of almost 20 million people found that diabetes significantly raises the risk of developing cancer, with women at even greater likelihood. The study highlights the need for more research into the role diabetes plays in cancer development and the importance of sex-specific research.
A new study by The George Institute for Global Health found that women in the US are less likely to receive high-intensity statins after a heart attack, despite guidelines recommending them. The study of over 88,000 adults suggests that adherence to these guidelines may be needed to prevent deaths from heart disease and stroke.
A large-scale study has shown that steroid treatment can reduce the duration of septic shock and time spent on life support therapy, but not necessarily lead to fewer deaths. The trial involved 3800 patients across five countries and found that steroids led to a more rapid resolution of shock and earlier discharge from intensive care.
A major new study has found that commonly used treatments to prevent acute kidney failure after angiogram procedures make no difference to health outcomes. Patients undergoing angiography should instead be treated with saline, which is cheaper and more readily available, say researchers.
A new study published in The Lancet Diabetes & Endocrinology suggests that a diet rich in omega-6 polyunsaturated fats may significantly reduce the risk of developing type 2 diabetes. Researchers found that individuals with higher levels of linoleic acid, the major omega-6 fat, had a lower chance of developing type 2 diabetes.
A new global health trial found that family-led stroke rehabilitation is ineffective in reducing disability and improving recovery outcomes. The ATTEND trial, published in The Lancet, suggests that effective rehabilitation requires professionals with years of training and specialized expertise.
A large trial involving over 11,000 patients reveals that sitting up or lying flat after a stroke makes no difference to their recovery. The study found that good nursing care is more important than head position in determining outcomes.
A new study published in the New England Journal of Medicine found that canagliflozin significantly reduced the risk of both cardiovascular disease and kidney disease in people with type 2 diabetes. The drug was shown to lower blood sugar levels and also provide protection against heart failure and renal decline.
A new study from The George Institute found that pregabalin treatment did not relieve pain but caused side effects like dizziness. Despite this, many patients reported being satisfied with the treatment, highlighting the need for alternative management options for sciatica.
A new report highlights a significant gender divide in the screening of patients for cardiovascular disease, with women being less likely to receive targeted screenings and treatments. The study found that younger women at high risk of CVD were 37% less likely than their male counterparts to have appropriate medications prescribed.
A new ultra-low dose four-in-one pill has shown remarkable results in treating high blood pressure, with all patients experiencing significant drops in blood levels within 4 weeks. Researchers also found no side effects associated with the treatment, which could be a game-changer for patients worldwide.
New research from The George Institute for Global Health reveals that commonly used non-steroidal anti-inflammatory drugs provide limited short-term pain relief and cause significant side effects. The study highlights the need for developing new therapies to treat back pain, which affects 80% of Australians during their lifetime.
A recent study published in the Journal of the American Society of Nephrology found that doubling dialysis hours did not improve overall quality of life for patients with kidney failure. However, some intermediate outcomes improved, such as blood pressure parameters and biochemistry measurements.
Babies with flat head syndrome are at heightened risk of motor, language, and cognitive delays. Early and prompt assessment and intervention are crucial to mitigate these delays.
Women from low socioeconomic backgrounds are 25% more likely to suffer a heart attack than disadvantaged men, according to a major new study. Cardiovascular disease is the leading cause of death in women worldwide, with an estimated 8.6 million deaths per year.
Research reveals weather plays no part in the symptoms associated with back pain and osteoarthritis, contrary to long-held beliefs. Higher temperatures slightly increase lower back pain risk but not clinically important.